लोड हो रहा है...

Advertisement

Entrada Therapeutics Says FDA Declines To Lift Clinical Hold On ENTR-601-44 IND Application

RTTNews | 568 दिनों पहले

Entrada Therapeutics Says FDA Declines To Lift Clinical Hold On ENTR-601-44 IND Application

(RTTNews) - Biopharmaceutical company Entrada Therapeutics, Inc. (TRDA) announced Wednesday the completion of dosing for the first and second cohorts of its Phase 1 clinical trial, ENTR-601-44-101.

Entrada plans to announce data from ENTR-601-44-101 in the second half of 2024.

The primary objective of Entrada's double-blind, single ascending dose Phase 1 clinical trial, which is expected to enroll approximately 40 participants, is to evaluate the safety and tolerability of a single dose of ENTR-601-44 in healthy male volunteers.

ENTR-601-44-101 will also evaluate pharmacokinetics and target engagement, as measured by exon skipping in the skeletal muscle.

Entrada was previously notified by the FDA that the IND for the Phase 1 clinical trial of ENTR-601-44 had been placed on clinical hold.

Despite providing additional information to the FDA, the Company was informed that the Agency declined to lift the clinical hold.

टैग: TRDA

read more

European Shares Edge Lower As Trade Optimism Fades

European Shares Edge Lower As Trade Optimism Fades

European stocks traded lower on Thursday, with U.S.-China trade tensions and escalating tensions in the Middle East keeping investors worried.

RTTNews | 6 मिनटों पहले

Asian Shares Mixed As Investors Await Details On Sino-US Trade Deal

Asian Shares Mixed As Investors Await Details On Sino-US Trade Deal

Asian stocks turned in a mixed performance on Thursday as a new U.S.-China trade deal provided few concrete details.

RTTNews | 33 मिनटों पहले

FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I

FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I

Medical devices maker Medtronic plc has urged customers to discontinue clinical use of the recently recalled certain Newport branded ventilators and certain related service parts after the U.S. Food and Drug Administration upgraded it to a Class I recall. According to the FDA, a Class I recall is the most serious type of recall, a situation where the use of, or exposure to, a violative product...

RTTNews | 51 मिनटों पहले

Pound Slides On Weak U.K. GDP Data

Pound Slides On Weak U.K. GDP Data

The British pound weakened against other major currencies in the European session on Thursday, as U.K. economy shrank more than expected in April largely reflecting a fall in services output.

RTTNews | 1घंटे 4 मिनट पहले

Pound Slides Against Majors

Pound Slides Against Majors

The British pound weakened against other major currencies in the European session on Thursday.

RTTNews | 1घंटे 18 मिनट पहले

Commodity Currencies Slide Amid Rising Geopolitical Risks, Yen Rises

Commodity Currencies Slide Amid Rising Geopolitical Risks, Yen Rises

The commodity currencies such as Australia, the New Zealand and the Canadian dollars weakened against other major currencies in the Asian session on Thursday, as rising geopolitical tensions in the Middle East weighed on market sentiment.

RTTNews | 1घंटे 31 मिनट पहले

Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the Asian session on Thursday.

RTTNews | 2घंटे 22 मिनट पहले

Canadian Dollar Drops Against Majors

Canadian Dollar Drops Against Majors

The Canadian dollar weakened against most major currencies in the Asian session on Thursday.

RTTNews | 3घंटे 2 मिनट पहले

शर्तें | गोलनीयता | साइट का मैप | Site Map Calendar

&प्रतिलिपि; 2025 Myfxbook Ltd. सर्वाधिकार सुरक्षित.

उच्च जोखिम चेतावनी: फॉरन एक्सचेंज ट्रेडिंग में उच्च स्तर का खतरा होता है जो हर निवेशकों के लिए सही नहीं हो सकता. लीवरेज अधिकतम खातर और हानि के अनावरण को उत्पन्न करता है. इससे पहले कि आप निर्णय लें फॉरन एक्सचेंज में ट्रेड करने का, ध्यान अपने निवेश के उद्देश्यों, अनुभव स्तर, और खतरा उठाने की सहिष्णुता पर विचार करें. आप कुछ या अपनी प्रारंभिक निवेश को खो सकते हैं. बिल्कुल भी उस पैसे को निवेश ना करें जो आप खोने को बर्दाश्त नहीं कर सकते. अपने आप को शिक्षित करें उन खतरों से जो फॉरन एक्सचेंज ट्रेडिंग से संबंधित हैं, और सलाह लें किसी स्वतंत्र आर्थिक या कर सलाहकार से अगर आपके पास कोई भी प्रश्न हैं तो. कोई भी डाटा या जानकारों जो दी जाती है वे केवल सूचनात्मक उद्देश्यों के लिए है, और यब ट्रेडिंग आशय या सलाह पर नियत नहीं है. पिछले निष्पादन भविष्य के परिणामों के लिए परियाचक नहीं हैं.